Bay State Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.

Press releases published on June 5, 2026

Jun. 5, 2026

Chambers Recognizes Wagner Law Group, Harold Ashner, Eric Keller, Andrew Oringer, Roberta Casper Watson, Stephen Wilkes

Indeterminate EIN Presswire

Jun. 5, 2026

Influential Women: Healthcare operations leader Carolyn Hackett excels in global delivery & strategic problem-solving.

Indeterminate EIN Presswire

Jun. 5, 2026

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Indeterminate GlobeNewswire

Jun. 5, 2026

Greenmen Builders Taps Building Science for Home Remodeling in Massachusetts

Indeterminate EIN Presswire

Jun. 5, 2026

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Jun. 5, 2026

Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

Jun. 5, 2026

AI Integration in Biorefinery Operations to Drive $400M+ in Annual Savings as Industry Pursues Carbon Neutrality Goals

Indeterminate GlobeNewswire

Jun. 5, 2026

UltraSight™ to Participate in Mayo Clinic Innovation Summit Focused on the Future of Cardiovascular Care

Indeterminate EIN Presswire

Jun. 5, 2026

MACOM IMS 2026 Product Announcements for Satellite Communications

Indeterminate GlobeNewswire

Jun. 5, 2026

Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Nano Dimension Issues Letter from Chief Executive Officer, David Stehlin

Indeterminate GlobeNewswire

Jun. 5, 2026

Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Indeterminate GlobeNewswire

Jun. 5, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development

Indeterminate GlobeNewswire

Jun. 5, 2026

Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027

Indeterminate GlobeNewswire

Jun. 5, 2026

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)

Indeterminate GlobeNewswire